Andrew Bae

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Cooley advised COUR Pharmaceuticals, a clinical-stage biotechnology company focused on the development of first-in-class disease-modifying therapies designed to induce antigen-specific tolerance for immune-mediated diseases, on the close of its $105 million Series A financing.

Cooley advised Allovue, a top provider of K-12 financial planning, budgeting and analytics software in the US, on its acquisition by PowerSchool, a leading provider of cloud-based software for K-12 education in North America.

Read more

Cooley advised Fontainebleau Aviation, a part of Fontainebleau Development’s luxury services division, on its partnership with Skyservice Business Aviation.

Cooley advised Midwestern Electric, a portfolio company of Canada-based private equity firm CAI Capital Partners and a provider of electrical infrastructure services, on its acquisition of Kuharchik Construction and Wyoming Electric & Signals.